Latest Form 4 insider transactions

NYSE
Tracy P. Palandjian, a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.
NYSE
Michael P. Garthwaite, VP (Pres., Products Pipelines) of Kinder Morgan, Inc., sold 1,550 shares of common stock on August 17, 2026 for $32.65 per share.
NYSE
Eric J Aumen, Chief Accounting Officer of Under Armour, Inc., reported a transaction in 3,568 shares of common stock on August 15, 2026.
NYSE
Alissa Michelle Starzak, Chief Legal Officer of Cloudflare, Inc., reported a transaction in 3,775 shares of common stock on August 15, 2026.
NASDAQ
Lindsay J. Radkoski, CMO, U.S. of Wendy's Co, reported multiple transactions in common stock on August 15, 2026.
NASDAQ
Laura Francis, Chief Executive Officer and a Director of SI-BONE, Inc., sold 14,956 shares of common stock on August 17, 2026.
NYSE
Thomas J Seifert, Chief Financial Officer of Cloudflare, Inc., reported a transaction in 2,944 shares of common stock on August 15, 2026.
NYSE
Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc., sold 32,710 shares of common stock on August 14, 2026 for $250.00 per share.
NASDAQ
David Zawitz, Chief Operating Officer of Verrica Pharmaceuticals Inc., purchased 6,000 shares of common stock on August 17, 2026 for $4.98 per share.
NASDAQ
Noah L. Rosenberg, CMO of Verrica Pharmaceuticals Inc., purchased 6,230 shares of common stock on August 17, 2026.
NASDAQ
Jayson Rieger, CEO and President and a Director of Verrica Pharmaceuticals Inc., purchased 25,000 shares of common stock on August 14, 2026.
NASDAQ
John J. Kirby, Interim CFO of Verrica Pharmaceuticals Inc., purchased 5,000 shares of common stock on August 18, 2026 for $4.93 per share.
NASDAQ
James Rolke, Chief Executive Officer and a Director of Revelation Biosciences, Inc., received 208,076 shares of common stock on August 17, 2026.
Hyunsu Jung, See Remarks and a Director of Eyenovia, Inc., reported a transaction in 40,000 shares of common stock on August 16, 2026.
NASDAQ
Lakhmir S Chawla, a Director of Revelation Biosciences, Inc., received 32,011 shares of common stock on August 17, 2026.
NASDAQ
Chester Stanley Zygmont Iii, Chief Financial Officer of Revelation Biosciences, Inc., reported multiple transactions in common stock on August 17, 2026.
NYSE
Leah Marie Trzcinski, Chief Legal Officer of Donnelley Financial Solutions, Inc., reported a transaction in 1,234 shares of common stock on August 17, 2026.
NASDAQ
Jess Roper, a Director of Revelation Biosciences, Inc., received 32,011 shares of common stock on August 17, 2026.
NASDAQ
Jennifer Carver, a Director of Revelation Biosciences, Inc., received 32,011 shares of common stock on August 17, 2026.
NYSE
Sylvia Jean Young, a Director of Pediatrix Medical Group, Inc., reported a transaction in 18,500 shares of common stock on August 14, 2026.
NYSE
Janel Riley, Chief Accounting Officer of Cloudflare, Inc., reported a transaction in 4,135 shares of common stock on August 15, 2026.
NASDAQ
Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr of SI-BONE, Inc., sold 3,725 shares of common stock on August 17, 2026.
NYSE
Scott H Baxter, Chairman and CEO and a Director of Kontoor Brands, Inc., sold 184,403 shares of common stock on August 13, 2026.
NASDAQ
John Calys, EVP, Chief Financial Officer of Verisign Inc/Ca, reported multiple transactions in common stock on August 15, 2026.
NYSE
Matthew Prince, CEO & Board Co-Chair, a Director and 10% owner of Cloudflare, Inc., reported a transaction in 19,937 shares of common stock on August 15, 2026.
NASDAQ
Jonsson Sigurgeir Orn, Chief Technology Officer of Better Home & Finance Holding Co, reported multiple transactions in common stock on May 1, 2026.
NYSE
Cara M. Hair, SVP, CORP. SERVICES & CLO of Helmerich & Payne, Inc., sold 11,149 shares of common stock on August 17, 2026 for $44.27 per share.
NYSE
Fory Musser, Senior VP, Development of Venture Global, Inc., sold 469,547 shares of common stock on August 14, 2026.
NYSE
Carolann I Haznedar, a Director of Enviri Corp, purchased 4,875 shares of common stock on August 17, 2026 for $20.46 per share.
NASDAQ
Anshul Maheshwari, Chief Financial Officer of SI-BONE, Inc., sold 4,665 shares of common stock on August 17, 2026.